New publication: Pharmacological CDK46 inhibition promotes vulnerability to lysosomotropic agents in breast cancer

10 February 2025

๐Ÿ“– Title: โ€œPharmacological CDK4/6 inhibition promotes vulnerability to lysosomotropic agents in breast cancer.โ€

๐Ÿ–Š๏ธ Authors: Nehme J, Maassen S, Bravaccini S, Zanoni M, Gianni C, De Giorgi U, Soto-Gamez A, Altulea A, Gheorghe T, Wang B, Demaria M

๐Ÿ›๏ธ Published in: EMBO J

๐ŸŽ‰ Congratulations to the authors!

๐Ÿ”— View on PubMed

Publication Image

Last update: 16-September-2025